Nalaganje...
Pharmacogenomics, Evidence, and the Role of Payers
Initial enthusiasm for the potential of pharmacogenomics (PGx) to transform medical practice has been tempered by the reality that the process of biomarker discovery, validation, and clinical qualification has been disappointingly slow, with a limited number of PGx tests entering the marketplace sin...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836944/ https://ncbi.nlm.nih.gov/pubmed/19204417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000189627 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|